Metraipolis › archive › dc_9cbc8cc37537

Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB — Europe PMC PMID:41750382

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41750382
DOI
10.3390/biom16020313
License (as archived)
solo-consultazione
Archived
2026-11-05T18:01:38.064Z
SHA-256 of the archived text
35f123268d7430aacfdf6a7364bf3b5e70ea720208a2fbb048a5f11cd0939928
Stable URL of this page
https://metraipolis.com/documento/dc_9cbc8cc37537

How to cite

Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB — Europe PMC PMID:41750382 — Europe PMC (en), https://europepmc.org/article/MED/41750382 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9cbc8cc37537 (Metraipolis archive dc_9cbc8cc37537, sha256 35f123268d7430aacfdf6a7364bf3b5e70ea720208a2fbb048a5f11cd0939928)
BibTeX
@misc{dc9cbc8cc37537,
  title = {Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB — Europe PMC PMID:41750382},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41750382},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9cbc8cc37537; sha256 35f123268d7430aacfdf6a7364bf3b5e70ea720208a2fbb048a5f11cd0939928},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41750382. Agents can read the archived copy with the MCP tool read_document.